---
title: "Coadministration of covid and flu vaccination"
subtitle: "Design 2: Operating Characteristics"
date: Apr 9, 2021
author: MAJ
output:
  xaringan::moon_reader:
    self_contained: true
    lib_dir: libs
    nature:
      highlightStyle: github
      highlightLines: true
---


```{css, echo = FALSE}
.pull-left-tiny {
  float: left;
  width: 47%;
  font-size: 12px;
}
.pull-right-tiny {
  float: right;
  width: 47%;
  font-size: 12px;
}
```

<!--
## -----------------------------------------------------------------------------
##
## Script name: design2.Rmd
##
## Purpose of script: extract summaries from the simulation outputs
##
## Author: MAJ
##
## Date Created: 2021-04-07
##
## -----------------------------------------------------------------------------
##
## Renders pre-made figures and tables obtained from `process_results.R` script
## into a xaringan presentation.
##
## -----------------------------------------------------------------------------
-->


```{r setup, include=FALSE}
knitr::opts_chunk$set(echo = FALSE)
```


## Introduction

+ Mod/Sev AE in covid 19 vaccination coadministered with flu vs. coadministered with placebo vaccine

+ Two brands (AZ and PF) with two doses

+ Participants enrol **either** at time of covid dose 1 (cohort 1) or 2 (cohort 2) 

+ Membership to cohort 1 and cohort 2 is mutually exclusive

+ Participants in each cohort are randomised to:
  + arm 1: CVD+FLU followed by PBO 7 days later
  + arm 2: CVD+PBO followed by FLU 7 days later
  


<!--
Partially pool over dose

+ We adopt the occurrence of moderate (or worse) reaction by day 7 as the (dichotomised) outcome of interest and evaluate whether:
  1. coadminstration of covid 19 and flu vaccinations has an unacceptable level of reactivity relative to administration of covid 19 alone;  
  
  2. coadministration of covid 19 and flu vaccinations results in no more than a 20% increase (in absolute terms) in reactivity relative to administration of covid 19 alone.
  -->

---
class: left, top
## Introduction

+ Variation in both the brand and cohort (first or second dose of CVD vaccination)

```{r, out.width='90%', out.height='50%', fig.align='center'}
knitr::include_graphics('../fig/design2.png')
```

+ Simulations look at CVD+FLU vs. CVD+PBO by brand and cohort (ignore FLU vs. PBO data)

  + Secondary - compare brands AZ vs PF
  + Secondary - compare coad vs. mono

---
class: left, top
## Data

+ Single random dataset

```{r, out.width='70%', out.height='35%', fig.align='center'}
knitr::include_graphics('../fig/dat_ex1.png')
```

---
class: left, top
## Model

+ Proportion with mod/sev AE (CVD+FLU vs CVD+PBO)

+ Partially pool across cohort and brand

$$
\begin{aligned}
\mathsf{Y}_{ijk} &\sim \mathsf{Bin}(n_{ijk}, \theta_{ijk}) \\
\theta_{ijk} &\sim \mathsf{Beta}(a_{k}, b_{k}) \\
\mu_{k} &\sim \mathsf{Beta}(1, 1) \\
\eta_{k} &\sim \mathsf{Exponential}(\eta_0)
\end{aligned}
$$

+ For cohort $i$ brand $j$ and coadministration arm $k$ with $a_k = \mu_k \eta_k$ and $b_k = (1-\mu_k) \eta_k$

+ Independent treatment arms;
  + arm 1: CVD+FLU followed by PBO 7 days later, $k=1$
  + arm 2: CVD+PBO followed by FLU 7 days later, $k=2$

+ Scales to more brands or additional coadministration arms (CVD+X) with shared control (CVD+PBO)

---
class: left, top
## Adaptation and decisions

+ Trial progression directed on evaluating the following identities:

$$
\begin{aligned}
\text{Pr}&(\theta_{i,j,k=2} - \theta_{i,j,k=1} > 0) > \gamma_1 \implies \text{Inferior} \\
\text{Pr}&(\theta_{i,j,k=2} - \theta_{i,j,k=1} < \delta) > \gamma_2 \implies \text{Non-inferior} 
\end{aligned}
$$

+ Inferior: higher proportion of mod/sev AE in CVD+FLU relative to CVD+PBO by brand and cohort

+ Non-inferior: proportion of mod/sev AE in CVD+FLU is no more than $\delta$ above proportion of mod/sev AE in CVD+PBO by brand and cohort

+ Trial recruitment for brand $k$ (both cohorts) suspended if either Inferiority or Non-inferiority triggered

+ $\theta_{i, j, k}$ probabilities of mod/sev reactions in CVD+FLU vs. CVD+PBO
  
+ $\delta = 0.2$ non-inferiority margin and 
  
+ $\gamma_z$ decision (inferiority, non-inferiority) thresholds specified to maintain an appropriate false positive rate for all $Z$ rules

<!-- .footnote[Should inferiority/non-inferiority be symmetrical?] -->

---
class: left, top
## Simulation

Assumes:

+ maximum of 1000 participants
+ enrolled 2000 per year
+ interim analyses from 500 to 1000, by 100
+ probability of reaction
  + AZ dose 1: 0.5, AZ dose 2: 0.4
  + PF dose 1: 0.3, PF dose 2: 0.5
+ effect sizes from 0 to 30% (in absolute terms)
+ non-inferiority margin of 20% (in absolute terms)
+ followup at 6.5 to 7.5 days after administration
+ 15% loss to followup
+ fixed randomisation 1:1 stratified by cohort and brand
+ 50% chance of being in either cohort
+ 70% chance of getting AZ


---
class: left, top
## Power (inferiority)

+ Power based solely on evaluating inferiority rule

```{r, out.width='75%', out.height='50%', fig.align='center'}
knitr::include_graphics('../fig/pwr_inf2.png')
```

---
class: left, top
## Sample size (inferiority)

+ Expected sample size based solely on evaluating inferiority rule

```{r, out.width='75%', out.height='50%', fig.align='center'}
knitr::include_graphics('../fig/n_inf2.png')
```

---
class: left, top
## Power and sample size (inferiority)

+ When effect size is zero, power indicates a false decision (we stopped the trial because we thought covid + flu was more reactive, when in fact it was not)

.pull-left[
.center[AZ]
]
.pull-right[
.center[PF]
]
.pull-left-tiny[
|    Effect size| Power| N| SD_N|
|-----:|------:|----:|----:|

]
.pull-right-tiny[
|    Effect size| Power| N| SD_N|
|-----:|------:|----:|----:|

]



---
class: left, top
## Power (noninferiority)

+ Power based solely on evaluating noninferiority rule

```{r, out.width='75%', out.height='50%', fig.align='center'}
knitr::include_graphics('../fig/pwr_ninf2.png')
```

---
class: left, top
## Sample size (noninferiority)

+ Expected sample size based solely on evaluating noninferiority rule

```{r, out.width='75%', out.height='50%', fig.align='center'}
knitr::include_graphics('../fig/n_ninf2.png')
```

---
class: left, top
## Power and sample size (noninferiority)

+ When effect size is greater than NI margin (0.2) power indicates a false decision (we stopped the trial because we thought covid + flu was no more than 20% reactive, when in fact it was not)

.pull-left[
.center[AZ]
]
.pull-right[
.center[PF]
]
.pull-left-tiny[
|    Effect size| Power| N| SD_N|
|-----:|------:|----:|----:|

]
.pull-right-tiny[
|    Effect size| Power| N| SD_N|
|-----:|------:|----:|----:|

]

---
class: left, top
## Power (inferiority and noninferiority)

+ Power based on evaluating inferiority and noninferiority rules

```{r, out.width='75%', out.height='50%', fig.align='center'}
knitr::include_graphics('../fig/pwr_cmb2.png')
```


---
class: left, top
## Sample size (inferiority and noninferiority)

+ Expected sample size based on evaluating inferiority and noninferiority rules

```{r, out.width='75%', out.height='50%', fig.align='center'}
knitr::include_graphics('../fig/n_cmb2.png')
```

---
class: left, top
## Power and sample size (inferiority and noninferiority)

.pull-left[
.center[AZ]
]
.pull-right[
.center[PF]
]
.pull-left-tiny[
|    Effect size| Power| N| SD_N|
|-----:|------:|----:|----:|
| 0.000|  1.000|  587|  150|
| 0.050|  1.000|  733|  210|
| 0.075|  1.000|  824|  205|
| 0.100|  1.000|  877|  183|
| 0.125|  1.000|  880|  182|
| 0.150|  0.999|  829|  198|
| 0.200|  1.000|  665|  188|
| 0.225|  0.999|  597|  151|
| 0.250|  0.998|  549|  106|
| 0.300|  1.000|  510|   45|

]
.pull-right-tiny[
|    Effect size| Power| N| SD_N|
|-----:|------:|----:|----:|
| 0.000|  1.000|  750|  215|
| 0.050|  0.996|  899|  176|
| 0.075|  0.986|  938|  149|
| 0.100|  0.969|  969|  105|
| 0.125|  0.940|  969|  108|
| 0.150|  0.908|  947|  134|
| 0.200|  0.842|  835|  202|
| 0.225|  0.808|  759|  209|
| 0.250|  0.839|  675|  190|
| 0.300|  0.922|  583|  133|
]
